Proximal disease extension and related predicting factors in ulcerative proctitis

References

• Nedelciuc O, Pintilie I, Dranga M, Mihai C, Prelipcean CC. Quality of life in patients with ulcerative colitis. Rev Med Chir Soc Med Nat Iasi 2012;116:756–60.
   PubMedGoogle Scholar
• Zhang CK, Hewett J, Hemming J, Grant T, Zhao H, Abraham C, et al. The influence of depression on quality of life in patients with inflammatory bowel disease. Inflamm Bowel Dis 2013;19:1732–9.
   PubMed Web of Science ®Google Scholar
• Katz J. The course of inflammatory bowel disease. Med Clin North Am 1994;78:1275–80.
   PubMed Web of Science ®Google Scholar
• Brostrom O. Prognosis in ulcerative colitis. Med Clin North Am 1990;74:201–18.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Jung ES, Lee JH, Hong SP, Kim TI, Kim WH, et al. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis. Hepatogastroenterology 2012;59:1415–20.
   PubMed Web of Science ®Google Scholar
• Choi CH, Kim YH, Kim YS, Ye BD, Lee KM, Lee BI, et al. [Guidelines for the management of ulcerative colitis]. Korean J Gastroenterol 2012;59:118–40.
   PubMedGoogle Scholar
• Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987;317:1625–9.
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005;353:2462–76.
   PubMed Web of Science ®Google Scholar
• Turner D, Seow CH, Greenberg GR, Griffiths AM, Silverberg MS, Steinhart AH. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis. Clin Gastroenterol Hepatol 2009;7:1081–8.
   PubMed Web of Science ®Google Scholar
• Lewis JD, Chuai S, Nessel L, Lichtenstein GR, Aberra FN, Ellenberg JH. Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis. Inflamm Bowel Dis 2008;14:1660–6.
   PubMed Web of Science ®Google Scholar
• Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 2004;18:463–79.
   PubMed Web of Science ®Google Scholar
• Henriksen M, Jahnsen J, Lygren I, Sauar J, Kjellevold O, Schulz T, et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis 2006;12:543–50.
   PubMed Web of Science ®Google Scholar
• Fdez-Morera JL, Rodrigo L, Lopez-Vazquez A, Rodero SR, Martinez-Borra J, Nino P, et al. MHC class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis. Hum Immunol 2003;64:816–22.
   PubMed Web of Science ®Google Scholar
• Hoie O, Wolters F, Riis L, Aamodt G, Solberg C, Bernklev T, et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 2007;102:1692–701.
   PubMed Web of Science ®Google Scholar
• Solberg IC, Lygren I, Jahnsen J, Aadland E, Hoie O, Cvancarova M, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009;44:431–40.
   PubMed Web of Science ®Google Scholar
• Allison J, Herrinton LJ, Liu L, Yu J, Lowder J. Natural history of severe ulcerative colitis in a community-based health plan. Clin Gastroenterol Hepatol 2008;6:999–1003.
   PubMed Web of Science ®Google Scholar
• Lee JH, Cheon JH, Kim ES, Chung MJ, Kang W, Kim DH, et al. The prevalence and clinical significance of perinuclear anti-neutrophil cytoplasmic antibody in Korean patients with ulcerative colitis. Dig Dis Sci 2010;55:1406–12.
   PubMed Web of Science ®Google Scholar
• Lee JH, Cheon JH, Moon CM, Park JJ, Hong SP, Kim TI, et al. Do patients with ulcerative colitis diagnosed at a young age have more severe disease activity than patients diagnosed when older? Digestion 2010;81:237–43.
   PubMed Web of Science ®Google Scholar
• Meucci G, Vecchi M, Astegiano M, Beretta L, Cesari P, Dizioli P, et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol 2000;95:469–73.
   PubMed Web of Science ®Google Scholar
• Langholz E, Munkholm P, Davidsen M, Nielsen OH, Binder V. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996;31:260–6.
   PubMed Web of Science ®Google Scholar
• Ghirardi M, Nascimbeni R, Mariani PP, Di Fabio F, Salerni B. [Course and natural history of idiopathic ulcerative proctitis in adults]. Ann Ital Chir 2002;73:155–8; discussion 8-9.
   PubMedGoogle Scholar
• Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993;38:1137–46.
   PubMed Web of Science ®Google Scholar